| Members |
targetComponentId |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| T-poäng vid DXA-skanning av ländrygg |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Z-poäng vid DXA-skanning av ländrygg |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine operations NOS |
Surgical procedure on lumbar spine (procedure) |
| fynd som rör TNM-stadium i lunga |
American Joint Committee on Cancer allowable value |
| LE-cell |
Lupus erythematosus cell |
| Luteinizing hormone releasing factor |
Gonadotropin releasing factor |
| Luteinizing hormone releasing factor preparation |
Product containing gonadotropin releasing factor (product) |
| Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| lutropin alfa 75 IE, pulver för beredning av injektionsvätska, + spädningsvätska |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Luy's nucleus (body structure) |
Structure of subthalamic nucleus of Luy (body structure) |
| lymfadenoid struma |
Hashimoto thyroiditis |
| Lymphadenopathy-associated virus, type II (LAV-II) |
Human immunodeficiency virus type 2 |
| lymfangiom |
Benign lymphangioma |
| Lymphatic incision NOS |
Incision of lymphatic system structure |
| Lymphatic incision NOS |
Incision of lymphatic system structure |
| Lymphocystis disease virus group |
Genus Lymphocystivirus (organism) |
| lymfatisk leukemi, kategori |
Lymphoid leukaemia |
| Lymphoma morphology |
Malignant lymphoma |
| lymfoproliferativ sjukdom |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
| Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
| Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
| Lymphosarcoma of extranodal AND/OR solid organ site |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of intra-abdominal lymph nodes |
Mixed cell type lymphosarcoma of intra-abdominal lymph nodes |
| Lymphosarcoma of intrapelvic lymph nodes |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of intrathoracic lymph nodes |
Mixed cell type lymphosarcoma of intrathoracic lymph nodes (disorder) |
| Lymphosarcoma of lymph nodes of axilla AND/OR upper limb |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of head, face AND/OR neck (disorder) |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of inguinal region AND/OR lower limb |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of multiple sites |
Malignant lymphoma of lymph nodes |
| Lymphosarcoma of spleen |
Non-Hodgkin's lymphoma (clinical) |
| frystorkat pulver till injicerbar liposomsuspension |
Lyophilized powder for conventional release suspension for injection (dose form) |
| lypressinallergi |
Allergy to antidiuretic hormone |
| Lysis of adhesions of abdomen |
Lysis of adhesions of peritoneum |
| Lückenschadel |
Craniolacunia |
| M+nage E trois |
Ménage à trois |
| stadium M0 |
American Joint Committee on Cancer cM0 (qualifier value) |
| M1 (4): fjärrmetastas |
American Joint Committee on Cancer cM1 (qualifier value) |
| M1 (4B): fjärrmetastas |
American Joint Committee on Cancer cM1 (qualifier value) |
| stadium M1 |
American Joint Committee on Cancer cM1 (qualifier value) |
| M1: fjärrmetastas [inklusive metastas i ipsilaterala supraklavikulära lymfknutor] |
American Joint Committee on Cancer cM1 (qualifier value) |
| M1: fjärrmetastas, inklusive separat(a) tumörknuta(or) i en annan lob (ipsilateral eller kontralateral) |
American Joint Committee on Cancer cM1 (qualifier value) |
| M1a (3): graviditetsrelaterad trofoblasttumör med spridning till lungorna med eller utan engagemang av genitalkanal |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a (3A): graviditetsrelaterad trofoblasttumör med spridning till lungorna med eller utan engagemang av genitalkanal utan riskfaktorer |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a (3B): graviditetsrelaterad trofoblasttumör med spridning till lungorna med eller utan engagemang av genitalkanal med en riskfaktor |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a (3C): graviditetsrelaterad trofoblasttumör med spridning till lungorna med eller utan engagemang av genitalkanal med två riskfaktorer |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a: metastas i icke-regional lymfknuta eller lunga |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1a: metastas i icke-regional lymfknuta |
American Joint Committee on Cancer cM1a (qualifier value) |
| M1b (4): alla övriga metastaslokalisationer |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b (4A): alla övriga metastaslokalisationer utan riskfaktorer |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b (4B): alla övriga metastaslokalisationer med en riskfaktor |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b (4C): alla övriga metastaslokalisationer med två riskfaktorer |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b: skelett |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1b: fjärrmetastas i annat än icke-regionala lymfkörtlar och lungor |
American Joint Committee on Cancer cM1b (qualifier value) |
| M1c: annan/andra lokalisation(er) |
cM1c |
| MV |
megavolt (qualifier value) |
| syndrom med MYH9-relaterad makrotrombocytopeni |
MYH9 related disease |
| Machine tool operator |
Machine-tool operator (general) |
| makrill, livsmedel |
Mackerel (substance) |
| överdos av makrolid |
Macrolide antibacterial overdose (disorder) |
| mafenidacetat 5 %, pulver |
Product containing only mafenide (medicinal product) |
| mafenidacetat 85 mg/g, hudkräm |
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| mafenidacetat 85 mg/g, kräm |
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| Magaldrate 800mg/5mL suspension |
Product containing precisely magaldrate 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Magnesium aspartate hydrochloride |
Product containing magnesium aspartate (medicinal product) |
| magnesiumklorid 200 mg/ml, injektionsvätska, lösning, ampull |
Product containing only magnesium chloride in parenteral dose form (medicinal product form) |
| magnesiumcitratpulver 17,7 g, dospåse |
Product containing only magnesium citrate (medicinal product) |
| magnesiumsalicylat 467 mg, kapseltablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumsalicylat 467 mg, tablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumsalicylat 500 mg, kapseltablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumsalicylat 500 mg, tablett |
Product containing only magnesium salicylate in oral dose form (medicinal product form) |
| magnesiumtillägg |
Magnesium compound |
| magnesiumtrisilikat + belladonna 0,15 mg, tablett |
Belladonna alkaloid and magnesium trisilicate only product |
| magnesiumbaserat antacidum |
Magnesium compound |
| Major amblyoscope |
Major amblyoscope (physical object) |
| klinisk handläggningsplan för egentlig depression |
Major depressive disorder clinical management plan |
| större puerperal infektion |
Postnatal infection |
| fynd som rör TNM-stadieindelning av tumör i större spottkörtel |
American Joint Committee on Cancer allowable value |
| större torakotomi med öppen intrapleural lösning av lunga |
Therapeutic pneumothorax |
| ringer obscena telefonsamtal |
Telephone scatologia |
| malation 1 %, krämschampo |
Malathion 10 mg/mL shampoo |
| manlig erektionsstörning |
Erectile dysfunction |
| fästman till patienten |
Male fiance |
| peritonit i manligt bäcken |
Pelvic peritonitis |
| extrakt specifikt för maleinsyraanhydrid |
Maleic anhydride |
| malign adenomatös tumör, kategori |
Malignant adenomatous neoplasm (morphologic abnormality) |
| primär malign blodkärlstumör |
Malignant blood vessel neoplasm |
| malign epitelial tumör, kategori |
Malignant epithelial neoplasm |
| malign fibrohistiocytär tumör, kategori |
Malignant fibrohistiocytic neoplasm (morphologic abnormality) |
| malignt gliom, kategori |
Glioma, malignant (morphologic abnormality) |
| malign histiocytär tumör |
Malignant histiocytic neoplasm (morphologic abnormality) |
| Malignant histiocytosis |
Malignant histiocytosis |
| malign histiocytos, extranodal och/eller organlokaliserad |
Malignant histiocytosis (clinical) |
| malign histiocytos i lymfknutor i axill och/eller arm |
Malignant histiocytosis of lymph nodes of upper limb |
| malign histiocytos i lymfknutor i inguinalregion och/eller ben |
Malignant histiocytosis of lymph nodes of lower limb (disorder) |
| malign histiocytos i lymfknutor i inguinalregion och ben |
Malignant histiocytosis of lymph nodes of lower limb (disorder) |
| Malignant hypothermia due to anesthetic |
Hypothermia caused by anesthetic (finding) |
| malignt lymfangiom |
Lymphangiosarcoma |
| malignt lymfom, kategori |
Malignant lymphoma |
FHIR